在固体瘤中,综合系统性免疫-炎症指数 (SII) 和预后营养指数 (PNI) 的预后值
Yan Zhang1, Min Tang1, Qian-Hui Gu1
1Department of Oncology & Radiotherapy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, 215300, People's Republic of China.
Cancer management and research
|July 14, 2025
概括
高的全身免疫炎症指数 (SII) 和低的预后营养指数 (PNI) 预测了更糟糕的癌症结果. 患有高SII和低PNI的患者面临最差的生存率,突出了他们的预后价值.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 营养科学 营养科学
背景情况:
- 炎症和营养状况对于癌症的发展和进展至关重要.
- 系统性免疫炎症指数 (SII) 和预后营养指数 (PNI) 是癌症的预后标志物.
- 评估治疗前的SII和PNI可以预测各种癌症类型的患者结果.
研究的目的:
- 评估治疗前SII和PNI对癌症患者预后的预测价值.
- 在预测结果时确定SII和PNI的最佳切割值.
- 确定高SII和低PNI对整体存活时间的综合影响.
主要方法:
- 对508例癌症病例 (2013年6月 - 2022年6月) 的回顾性分析.
- 从外周血液样本计算治疗前的SII和PNI.
- 使用接收器运行特征 (ROC) 分析确定截止值.
- 与临床病理因素的关联分析和使用考克斯回归和卡普兰-梅尔方法的预后.
主要成果:
- 预处理前最优的截止值被确定为SII = 792.0和PNI = 49.825.
- 较高的SII和较低的PNI与更糟糕的患者预后有关.
- 患有高SII和低PNI的患者表现出最低的整体存活率 (OS) (p < 0.001).
- 多变量分析证实了瘤阶段,BMI,SII和AGR作为OS的独立预后标志物.
结论:
- 治疗前SII升高是癌症患者显著的独立预后因素.
- 高SII和低PNI的组合表明预后最差.
- 这些炎症和营养标志物为癌症患者的治疗结果提供了宝贵的见解.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
426
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456


